- Home
- MHUA vs PRPH Comparison
MHUA vs PRPH Comparison
Compare MHUA & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHUA
- PRPH
- Stock Information
- Founded
- MHUA 1990
- PRPH 1989
- Country
- MHUA China
- PRPH United States
- Employees
- MHUA N/A
- PRPH N/A
- Industry
- MHUA Medical Specialities
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- MHUA Health Care
- PRPH Health Care
- Exchange
- MHUA Nasdaq
- PRPH Nasdaq
- Market Cap
- MHUA 11.8M
- PRPH 14.5M
- IPO Year
- MHUA 2022
- PRPH 1997
- Fundamental
- Price
- MHUA $0.42
- PRPH $0.43
- Analyst Decision
- MHUA
- PRPH
- Analyst Count
- MHUA 0
- PRPH 0
- Target Price
- MHUA N/A
- PRPH N/A
- AVG Volume (30 Days)
- MHUA 147.2K
- PRPH 2.5M
- Earning Date
- MHUA 09-19-2025
- PRPH 11-12-2025
- Dividend Yield
- MHUA N/A
- PRPH N/A
- EPS Growth
- MHUA N/A
- PRPH N/A
- EPS
- MHUA 0.40
- PRPH N/A
- Revenue
- MHUA $96,909,642.00
- PRPH $5,588,000.00
- Revenue This Year
- MHUA N/A
- PRPH $221.82
- Revenue Next Year
- MHUA N/A
- PRPH N/A
- P/E Ratio
- MHUA $1.22
- PRPH N/A
- Revenue Growth
- MHUA N/A
- PRPH N/A
- 52 Week Low
- MHUA $0.25
- PRPH $0.22
- 52 Week High
- MHUA $1.24
- PRPH $2.72
- Technical
- Relative Strength Index (RSI)
- MHUA 52.84
- PRPH 55.73
- Support Level
- MHUA $0.39
- PRPH $0.34
- Resistance Level
- MHUA $0.50
- PRPH $0.57
- Average True Range (ATR)
- MHUA 0.04
- PRPH 0.06
- MACD
- MHUA 0.00
- PRPH 0.01
- Stochastic Oscillator
- MHUA 49.53
- PRPH 41.62
About MHUA Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.